Sun Pharmaceutical Industries Inc is recalling 5,448 bottles of Lisdexamfetamine Dimesylate (60 mg), a prescription medication used to treat ADHD and Binge Eating Disorder. The recall was issued because the capsules failed dissolution testing during stability analysis, meaning the medication may not dissolve or release properly in the body. If you are taking this medication, please contact your doctor or pharmacist to discuss your treatment.
When a drug fails dissolution specifications, it may not be absorbed at the intended rate or amount, which can lead to inconsistent treatment of the patient's condition or reduced effectiveness of the medication. No reports of adverse events or injuries have been noted in the recall data.
You have 2 options:
Manufactured by: OHM Laboratories, New Brunswick, NJ 08901; Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512; Recall #: D-0516-2025.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.